A series of novel aryloxazolidine-2,4-diones was synthesized. A structure-activity relationship study of these compounds led to the identification of potent, orally active PPAR dual alpha/gamma agonists. Based on the results of efficacy studies in the db/db mice model of type 2 diabetes and the desired pharmacokinetic parameters, compound 12 was selected for further profiling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(03)00785-6 | DOI Listing |
Publication Analysis
Top Keywords
identification potent
8
potent orally
8
orally active
8
active ppar
8
ppar dual
8
dual alpha/gamma
8
alpha/gamma agonists
8
aryloxazolidinediones identification
4
agonists series
4
series novel
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!